feed,title,long_url,short_url
Benzinga,Nirsevimab reduced respiratory syncytial virus infections requiring medical care in healthy premature infants in Phase 2b trial,https://www.benzinga.com/pressreleases/20/07/g16843474/nirsevimab-reduced-respiratory-syncytial-virus-infections-requiring-medical-care-in-healthy-premat,https://j.mp/3hMWcOW
